placebo

[pluh-see-boh, plah-chey-boh]

noun

plural

placebos, placeboes 

1. Medicine/Medical, Pharmacology.

   1. a substance having no pharmacological effect but given merely to satisfy a patient who supposes it to be a medicine.

   2. a substance having no pharmacological effect but administered as a control in testing experimentally or clinically the efficacy of a biologically active preparation.

2. Roman Catholic Church.,  the vespers of the office for the dead: so called from the initial word of the first antiphon, taken from Psalm 114:9 of the Vulgate.

placebo

/ pləˈsiːbəʊ /

noun

1. med an inactive substance or other sham form of therapy administered to a patient usually to compare its effects with those of a real drug or treatment, but sometimes for the psychological benefit to the patient through his believing he is receiving treatment See also control group placebo effect

2. something said or done to please or humour another

3. RC Church a traditional name for the vespers of the office for the dead

placebo

1. A substance containing no medication and prescribed to reinforce a patient's expectation of getting well or used as a control in a clinical research trial to determine the effectiveness of a potential new drug.

placebo

1. A substance containing no active drug, administered to a patient participating in a medical experiment as a control.

Those receiving a placebo often get better, a phenomenon known as the placebo effect.

Word History and Origins

Origin of placebo¹

1175–1225 placebo for def. 2; 1775–85 placebo for def. 1; Middle English < Latin placēbō “I shall be pleasing, acceptable”

Word History and Origins

Origin of placebo¹

C13 (in the ecclesiastical sense): from Latin Placebo Domino I shall please the Lord (from the opening of the office for the dead); C19 (in the medical sense)

Example Sentences

Those who received the injectable version achieved statistically significant weight loss of up to 14.5% compared with 2.6% in people treated with a placebo.

Read more on MarketWatch

The company said Monday that the ingredient, called semaglutide, wasn’t superior to a placebo in reducing the progression of Alzheimer’s disease in the studies.

Read more on The Wall Street Journal

Participants on the highest dose of 36 milligrams lost around 10 percent of their body weight after 72 weeks, compared to two percent for the group taking a placebo, according to the study.

Read more on Barron's

The analyses evaluated three GLP-1 receptor agonists used for weight management and found that each one produced clinically important weight loss when compared with placebo.

Read more on Science Daily

Half received colchicine, while the rest were given either a placebo or no added medication on top of their typical care.

Read more on Science Daily